The forecast for the import of antibiotics to the US from 2024 to 2028 shows a steady decline in value, starting from 779.01 million US Dollars in 2024 and decreasing to 739.87 million US Dollars by 2028. This represents a continuous year-on-year decrease, with a Compound Annual Growth Rate (CAGR) reflecting a negative trend.
In 2023, the value of imported antibiotics was higher than in the forecasted period, indicating a downward trend in imports. This could be indicative of several factors, such as increased domestic production capacity, changes in demand, or shifts in regulatory policies.
Future trends to watch for include:
- Potential policy changes affecting drug regulation and importation.
- Developments in domestic antibiotic production capabilities.
- Global market dynamics and trade agreements impacting supply chains.
- Shifts in the healthcare sector influencing antibiotic demand.
